SOX9 and neoplasm: In contrast, when examining the broader set of clinicopathological variables, no statistically significant associations were identified between the expression levels of SOX9, GATA3, or GATA4 and features such as gender, patient age, tumor localization, histologic grade, tumor stage, inflammation, fibrosis, mitotic index, resection margin status, or recurrence (all p > 0.05).